Article Text


Unstudied infants: outcomes of moderately premature infants in the neonatal intensive care unit
  1. G J Escobar1,2,
  2. M C McCormick3,4,
  3. J A F Zupancic4,
  4. K Coleman-Phox1,
  5. M A Armstrong1,
  6. J D Greene1,
  7. E C Eichenwald5,
  8. D K Richardson4
  1. 1Kaiser Permanente Medical Care Program, Division of Research, Perinatal Research Unit, Oakland, CA, USA
  2. 2Kaiser Permanente Medical Center, Department of Pediatrics, Walnut Creek, CA, USA
  3. 3Department of Society, Human Development and Health, Harvard School of Public Health, Boston, MA, USA
  4. 4Department of Neonatology, Beth Israel Deaconess Medical Center, Boston
  5. 5Harvard Medical School, Department of Newborn Medicine, Brigham and Women’s Hospital, Boston
  1. Correspondence to:
    Dr Escobar
    Kaiser Permanente Medical Care Program, Division of Research, Perinatal Research Unit, 2000 Broadway, 2nd floor, Oakland, CA 94612, USA; gabriel.escobar{at}


Background: Newborns of 30–34 weeks gestation comprise 3.9% of all live births in the United States and 32% of all premature infants. They have been studied much less than very low birthweight infants.

Objective: To measure in-hospital outcomes and readmission within three months of discharge of moderately premature infants.

Design: Prospective cohort study including retrospective chart review and telephone interviews after discharge.

Setting: Ten birth hospitals in California and Massachusetts.

Patients: Surviving moderately premature infants born between October 2001 and February 2003.

Main outcome measures: (a) Occurrence of assisted ventilation during the hospital stay after birth; (b) adverse in-hospital outcomes—for example, necrotising enterocolitis; (c) readmission within three months of discharge.

Results: With the use of prospective cluster sampling, 850 eligible infants and their families were identified, randomly selected, and enrolled. A total of 677 families completed a telephone interview three months after hospital discharge. During the birth stay, these babies experienced substantial morbidity: 45.7% experienced assisted ventilation, and 3.2% still required supplemental oxygen at 36 weeks. Readmission within three months occurred in 11.2% of the cohort and was higher among male infants and those with chronic lung disease.

Conclusions: Moderately premature infants experience significant morbidity, as evidenced by high rates of assisted ventilation, use of oxygen at 36 weeks, and readmission. Such morbidity deserves more research.

Statistics from

Much of the recent neonatal outcomes literature focuses on babies weighing <1500 g at birth, who are usually <33 weeks gestation and who have very high mortality and morbidity.1 Less is known about premature infants at higher gestations. Rates of several outcomes (mortality,2 cerebral palsy,3–5 respiratory syncytial virus infection,6 short term hospital morbidity,7 and readmission8,9) in these infants are lower than in very premature infants but higher than in term infants.

Newborns born at 30–346/7 weeks gestation constitute 3.9% of all infants and 32% of all premature infants in the United States.10 Neonatal mortality in 30–34 week gestation infants in the United States is 18.5 per 1000 live births, substantially higher than the 6.9/1000 rate found in 35–36 week gestation infants and the 2.5/1000 rate found in term infants, but considerably lower than the 285.3/1000 rate in babies <30 weeks gestation.10

Moreover, these infants make up a substantial proportion of admissions to neonatal intensive care units (NICUs). In an internal data review for the year 2003 in the Kaiser Permanente Medical Care Program, 27% of all NICU admissions were 30–34 week babies. Similarly, for the years 2002 through 2004, 38% of all NICU admissions at the Brigham and Women’s Hospital in Boston were in this gestational age range and constituted 77% of all admissions <35 weeks.

To address this gap in the literature, we prospectively examined birth stay outcomes and three month follow up of a cohort of 30–34 week infants who survived the birth stay in California and Massachusetts. This report will focus on overall in-hospital outcomes and readmission in the first three months after discharge from the NICU. Other findings are reported elsewhere.11–16


Study population and sampling strategy

Our target population was infants born at 30–346/7 weeks gestation discharged alive from 10 hospitals in Massachusetts and California between 30 October 2001 and 28 February 2003. These centres (described in an appendix which is available on request from the corresponding author) were selected because of previous participation in our studies, including one on healthy, moderately premature infants17 and previous discharge information indicating that they could recruit 100 infants over the 15 month period. Admission to the NICU is mandatory for all babies born at <35 weeks gestation at these 10 centres.

At three sites where the volume of admissions was very high, sampling algorithms were developed to ensure that the final sample size of 100 was evenly distributed over the enrolment period. Despite the prior information, in four sites enrolment was slower than expected, and we reduced the target size to 60–65 infants so that all sites were collecting data throughout the same period.

Study sample and enrolment procedures

Infants eligible for the study included those admitted to the study sites within the target gestational age range as determined by the best obstetrician defined estimate. Infants with major malformations or chromosomal disorders were excluded. Where potential ambiguities existed—for example, with respect to anomalies—the decision to exclude an infant was made by consensus among the investigators.

At least once a week during the enrolment period, trained research assistants visited each site or contacted designated hospital staff to ascertain admission of potentially eligible infants. Using the admission log at each site and computerised tracking files, research assistants identified potentially eligible infants and followed their hospital course until 34 weeks postmenstrual age (PMA). At that point parents were given a study packet and asked to participate in the follow up interview.

Parents whom we were unable to contact before discharge or who failed to respond were contacted by mail nine weeks after discharge (a time frame mandated by institutional review boards) and invited to participate in the telephone survey.

Data collection

Data for this report were obtained from the NICU admission logs at each site, maternal and infant medical records, and a telephone survey of parents three months after hospital discharge. The basic data collection protocol was based on the Kaiser Permanente neonatal minimum data set,18 the score for neonatal acute physiology, version II,19 and previous studies.20–24 Trained research assistants entered data directly into laptop computers, and encrypted data were sent to the Boston data coordinating centre.

The telephone interview at three months after discharge captured information on resource use after discharge, readmission, parent perception of infant health, satisfaction with NICU care, and breast feeding. Trained interviewers using computer assisted telephone interviewing software administered the survey. Questions on illness, readmission, planned and unplanned medical visits, and early intervention were adapted from the one year survey used in the evaluation of the Robert Wood Johnson national perinatal regionalization demonstration program.25

Statistical analysis

Because sampling fractions were not equal across study sites, all statistical analyses involving the entire cohort (as opposed to site specific calculations) used analytical methods in which the data for each site were weighted by the site’s sampling fraction. For analyses involving outcomes after discharge, which were based on interview data, each site’s data were weighted by the proportion of infants actually followed up at that centre. Not all study hospitals routinely collected data on maternal and infant race, but this information was obtained consistently from all interviews. As race was not available in the chart review dataset but was available in the interview dataset, we compared the results of tables and multivariate models with and without race. There were no major differences in the results, so all of the tables in this report include race.

Initial selection of variables for multivariate models was based on the results of bivariate comparisons, biological plausibility, and results of previous studies.8,9,26,27 Variables were retained in the final multivariate models if they reached statistical significance in preliminary models or if they were clinically important.

All analyses were conducted using Stata statistical software, version 8 (Stata, College Station, Texas, USA) and controlled for clustering due to multiple births.

Human subjects

The eight institutional review boards with jurisdiction over the 10 sites approved this study. Except for one site, which required written consent for all parts of the study, collection of medical record data was approved for all eligible infants, and parental permission for the interview was required.


Figure 1 summarises study enrolment. Of the 1694 infants of 30–34 weeks gestation identified at the 10 study hospitals, 346 were found to be ineligible, leaving 1348 potential study subjects. Of these 1348 infants, 903 were randomly selected on the basis of the centre’s designated sampling fraction. Of the ineligible infants, 276 (80%) were transferred to another hospital where we could not track their outcomes, 27 (8%) did not meet the gestational age criteria of 30–346/7 weeks, 27 (8%) had a major congenital anomaly, 12 (3%) were ineligible because of parent language barriers or other social reasons, and four (1%) died before discharge. Of the remaining 903 eligible infants, 43 parents did not provide the required consent for the chart review, and 10 infants enrolled in excess of site specific goals were excluded, giving a total cohort of 850 infants for the examination of hospital based morbidity.

Figure 1

 Overview of identification, sampling, and study enrolment.

The parents of 64 (8%) of these 850 infants refused the three month interview, and interviews were not attempted for social reasons—for example, infants entering foster care—for 11 (1%). An additional 98 (12%) were lost to follow up. Thus interviews were completed for 677 (80%) of the eligible parents. Compared with the infants whose families completed the telephone survey, those whose families did not were not significantly different with respect to sex, birth weight, gestational age, proportion who were small for gestational age, the score for neonatal acute physiology, version II, assisted ventilation status, or chronic lung disease status.

Table 1 summarises cohort characteristics. The number of enrolled births listed is 1250 (not 850) because of weighting given different sampling fractions in the medical centres. Almost two thirds of the babies were 33–34 weeks gestation, and almost half experienced some form of assisted ventilation. The proportion of infants who received antenatal steroids was 66%, with considerable variation by gestational age, ranging from 45% among 34 week infants to 88% among 30 week infants. Mean PMA at discharge was 36.2 weeks. Most mothers had completed high school, and their mean age was 31 years. Annual income was at least $50 000 in 60% of the families.

Table 1

 Characteristics of 30–346/7 week gestation premature infants in the study

Table 2 summarises the in-hospital outcomes of the study infants. The rates of these outcomes were generally higher in babies 30–326/7 weeks than in those 33–346/7 weeks gestation. There were no differences between the two gestational age ranges in rates of pneumothorax, necrotising enterocolitis, or PMA at discharge ⩾36 weeks. Results obtained using stratification by birth weight were similar to those obtained using gestational age. Mean PMA at discharge was slightly lower in babies ⩾2000 g birth weight (36.0 weeks) than in those <2000 g (36.3 weeks, p  =  0.019). None of the 24.5% of infants screened by an ophthalmologist developed retinopathy of prematurity.

Table 2

 Rates of key in-hospital outcomes, stratified by gestational age and birth weight

Table 3 shows rates of readmission within three months of discharge. The overall readmission rate was 11.3% and varied considerably across centres (6.0–18.2%). In unadjusted comparisons, infants who experienced assisted ventilation for at least 72 hours, African-American infants, male infants, and infants with chronic lung disease (whether defined as oxygen use at 28 days of age or as oxygen use at 36 weeks PMA) were more likely to be readmitted.

Table 3

 Readmission within three months of discharge in the study cohort

Table 4 shows the results of a multivariate model that included infant sex, gestational age, chronic lung disease (defined as oxygen use at 36 weeks PMA), birth weight, race, and a combined hospital adverse outcome variable that included the occurrence of at least one of the following outcomes: sepsis/meningitis, pneumothorax, prolonged length of stay, or necrotising enterocolitis. Only male sex was a statistically significant predictor for readmission (adjusted odds ratio 1.93; 95% confidence interval 1.10 to 3.41). Having a birth weight ⩾2000 g was not protective. Incorporating maternal education and/or family income did not result in any substantial change in the odds ratios.

Table 4

 Multivariate analysis for readmission


We have conducted a prospective descriptive study of in-hospital outcomes and readmissions within three months of discharge in surviving infants born at 30 to 346/7 weeks gestation. These infants experience considerable in-hospital morbidity, and a substantial fraction are readmitted within three months of discharge.

Resource limitations precluded us from incorporating a term comparison group, but a limited number of denominator based studies for ⩾37 week babies suggest that the morbidity experienced by infants in our cohort is substantially higher. In our cohort, 45.7/1000 experienced assisted ventilation, which is more than 4 times higher than the 10.4/1000 rate found in term infants by Wilson et al.28 With respect to pneumothorax, three studies29–31 have reported rates ranging from 0.17 to 0.70/1000 live births; in contrast, the rate in our cohort was 16/1000. Chen et al32 reported a sepsis/meningitis rate of 1.6/1000 in term infants, also substantially lower than the 24.0/1000 rate in our cohort. If one only considers grade 3 or 4 intraventricular haemorrhages, the rate in our cohort (4.0/1000) is much higher than that reported by Jocelyn et al33 in term infants (0.49/1000). The difference may not be as great with respect to having any intraventricular haemorrhage, as some studies, which did not report haemorrhage grades, have documented such events in as many as 5% of all term infants.34,35 A recent article by Wang et al,7 which compared outcomes in near term (35–366/7 weeks) and term infants, also supports the notion that moderate degrees of prematurity are also associated with substantial morbidity.

Recent reports of readmission among term infants36–38 use a four to six week window rather than our three month interval. In these studies, readmission rates range from 19.0 to 39.5/1000. In addition, we were able to make comparisons with the readmission rate at three months in the ⩾37 week gestational age cohort of the Kaiser Permanente Medical Care Program in 2002, where this rate was 43.0/1000. Thus it seems reasonable to infer that 30–34 week gestation infants, whose readmission rate in the three months after hospital discharge was 113.0/1000, are at much higher risk than term infants.

Our analyses show that characteristics such as an infant’s sex and clinical variables—for example, chronic lung disease—have strong associations with in-hospital outcomes. We also found that male sex was a predictor for readmission in the three months after discharge, a finding that we cannot explain. In previous studies,39,40 we have reported an increased risk of severe (⩾25 mg/dl) jaundice in male infants ⩾36 weeks gestation. However, in another study involving readmission within two weeks of discharge in infants of all gestations, the increased risk in male infants was not limited to jaundice.9

Of importance is the fact that a birth weight of ⩾2000 g is not protective against assisted ventilation or readmission. Although a large body of evidence clearly shows that the key determinant for neonatal mortality and morbidity is gestational age, and although ultrasound gestational age assignment is becoming more widespread—for example, in the Kaiser Permanente Medical Care Program all pregnant women have at least one ultrasound—use of birth weight as a predictor remains quite common, in both the literature and clinical practice. Our study shows that babies whose weights might lead many clinicians to consider them to be “big premies” nonetheless experience considerable morbidity.

Our study does have important limitations. The first is that our sample of hospitals may not be representative. For example, at our study sites, admission to a special care setting is mandatory for babies <35 weeks gestation, a policy that may not be universal. It is conceivable that moderately premature infants in other locations could have better or worse outcomes than the ones we describe in this report. It is also possible that, as we excluded infants who were transferred (who, at these medical centres, are most likely to be babies who could safely be sent for convalescence at smaller hospitals), our sample may be relatively enriched with sicker moderately premature infants. Given the relatively low frequency of certain events—for example, only 3.2% of the cohort had chronic lung disease—our study may not have the power to detect associations between events occurring during the birth stay and subsequent outcome. Because this study was planned as an exploration of the factors affecting outcomes of moderately premature infants, we did not collect detailed utilisation data—for example, actual follow up services provided to families and infants—and we also have limited data on the obstetric management experienced by these infants. Clearly, future studies should capture such data because of its established impact on readmission rates.9 Future collaborative studies could address these issues.

It is very clear that, for many important neonatal outcomes, two important gradients exist. The first is a quantitative gradient, with an exponential decrease in the numbers of babies as gestational age decreases. However, adverse outcomes follow a gradient in the opposite direction, with increasing rates as gestational age decreases. Thus, for certain outcomes, the absolute burden to society may be greater from infants who are not as premature because there are more such infants. Consideration of these gradients suggests that a broader conceptual shift needs to be made in perinatal medicine and epidemiology. Such a shift needs to consider issues involving the care of infants as well as the study of the care infants receive.

In the presence of widespread practice variation and absence of specific, evidence based guidelines, which should include rational discharge planning strategies, it is conceivable that both clinicians and insurers may use tacit or “de facto” guidelines that treat these infants on the basis of their birth weight as well as presumed asymptomatic status. This could lead some infants to be treated—inappropriately—using guidelines defined for term infants. Professional societies such as the Royal College of Paediatrics and Child Health and the American Academy of Pediatrics should take an active role in defining gestational age specific guidelines for moderately premature infants. Such guidelines will probably need to go into greater detail with respect to gestational age ranges—that is, not simply group all babies <37 weeks into a single category.

The fact that so many moderately premature infants require some form of assisted ventilation suggests that assessment of the value of specific obstetric interventions aimed at prolonging pregnancy should take these infants’ outcomes into account. For example, not all obstetricians would attempt tocolysis at 33–34 weeks gestation. Another important issue that needs to be re-examined is the risk-benefit ratio of elective caesarean delivery for moderately premature infants. A recent randomised trial to prevent respiratory distress in term infants born by elective caesarean section provides a good example of the sort of questions that need to be addressed in moderately premature infants.41

What is already known on this topic

  • Premature infants are at higher risk of mortality and morbidity than term infants

  • Very low birthweight and very premature infants are at the highest risk of adverse outcomes

In developed nations, accurate gestational age measures have become more commonly available. Moreover, during analysis of any dataset, use of cut off points (particularly dichotomous ones) for continuous data entails information loss. Consequently, future studies on premature infants should: (a) base their cohorts on gestational age criteria, not birth weight; (b) report outcomes for specific weeks of gestation; (c) whenever possible, include gestational age as a continuous outcome in multivariate models.

In conclusion, given that previous studies may not have considered the contribution of moderate prematurity to overall outcomes rates, it may be necessary to re-examine certain existing assumptions about the costs and benefits of specific interventions. For example, if one bases certain obstetric interventions only on the outcomes experienced by very low birthweight infants, one may come to erroneous conclusions about the value or risk of such interventions among women presenting with preterm labour and moderate prematurity.

What this study adds

  • Moderately premature (30–34 weeks gestation) infants experience significant morbidity during their hospital stay after birth

  • Moderately premature infants have a very high readmission rate in the three months after discharge


This project was supported by the Agency for Healthcare Research and Quality (grant number 5 R01 HS 10131-02, “Unstudied Infants: Low Risk Babies in a High Risk Place”). We thank Dr Joseph Selby, Director of the Kaiser Permanente Division of Research, for reviewing the manuscript, and Ms Kimberley Harris for formatting the manuscript. In Massachusetts, the Beth Israel Deaconess Medical Center, the Brigham and Women’s, Lowell General, Newton-Wellesley, and Winchester hospitals participated in the study, and the California sites were the Kaiser Foundation Hospitals in Hayward, Santa Clara, San Francisco, and Walnut Creek, and the Alta Bates Medical Center in Berkeley. In Massachusetts, we are very grateful for the assistance we received from the Beth Israel Deaconess Medical Center’s Neonatologist in Chief, Dr DeWayne Pursley, as well as from the Nurse Manager, Jane Smallcomb; at the Winchester Hospital, we are grateful for the assistance we received from Dr Karen McAlmon, Medical Director, Special Care Nursery, and Ms Suzanne Murphy, Nurse Manager, Special Care Nursery; at the Lowell Hospital, we are grateful to Dr Mary Blackwell, Medical Director, Special Care Nursery, Dr Kim Chatson, Associate Director, Special Care Nursery, and Mary Beth Foley, Nurse Manager, Special Care Nursery; at the Newton-Wellesley Hospital, we are grateful to Dr Richard Wilker, Chief of Neonatology, Ms Karen Ross, Nurse Manager, Special Care Nursery, and Ms Karen Mueller, Assistant Nurse Manager, Special Care Nursery; at the Brigham and Women’s Hospital, we are grateful to Dr Steven Ringer, Director of the NICU, and Ms Marianne Cummings, Nurse Manager, NICU. We also wish to thank Rebecca Roberts and Chris Morgan for project support. In California, we thank the following neonatal intensive care unit directors for their support and assistance: Gilbert Duritz, MD, PhD, and Lee Reuben, MD, at the Alta Bates Medical Center; Jocelyn Alcantara, MD, Kaiser Permanente Hayward Medical Center; James Kantor, MD, and Carlos Botas, MD, Kaiser Permanente Medical Center San Francisco; Stephen Fernbach, MD, Kaiser Permanente Medical Center, Santa Clara; and Allen Fischer, MD, Kaiser Permanente Medical Center, Walnut Creek. We are also grateful for the assistance we received from Pamela Bigbee, RN, ICN Nurse Manager, and Rebecca Mitchell, RN, Assistant ICN Nurse Manager at the Kaiser Permanente Hayward Medical Center; Pat Keightley, RN, ICN Nurse Manager, and Nancy Taquino, RN, ICN Nurse Manager, at the Kaiser Permanente San Francisco Medical Center; Lisette Santos, RN, ICN Nurse Manager, and Bernadette Custodio, ICN Unit Assistant, at the Kaiser Permanente Santa Clara Medical Center; Shirley Dostal, RN, ICN Nurse Manager, Marilyn Taylor, RN, Assistant ICN Nurse Manager, Josie Franck, RN, Christine Retta, RN, and Noni Ettl, LCSW, at the Kaiser Permanente Walnut Creek Medical Center; and Katie Tobin, RN, Director, Women and Infants’ Services, Amarjit Sandhu, MD, Peggy Lindsley, RN, BSN, NICU Nurse Manager, Alison Brooks, RN, MS, Ann Frost, RN, Sue Wittstock, RN, Gail Levine, MD, and Deborah Wilson, RN, NNP. We also thank Rachel Warder, BS, Diane Lott-Garcia, Jeanne Holbrook, RN, and Christina Olguin at the Division of Research.


View Abstract


  • Published Online First 12 April 2006

  • Competing interests: none declared

  • Presented at a platform session at the May 2004 meetings of the Society for Pediatric Research in San Francisco, California, and at Bethesda, MD at the NICHD Workshop on Optimizing Care and Long-term Outcome of Near-term Pregnancy and the Near-term Newborn Infant in July of 2005.

  • D K Richardson is deceased.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.